Wilson v. Lilly

222 F.R.D. 99, 2004 U.S. Dist. LEXIS 10834, 2004 WL 1305859
District Court, D. Maryland·Decided June 14, 2004·No. No. CIV. AMD 04-400·Published·Cited by 6 cases

Opinion

MEMORANDUM OPINION

DAVIS, District Judge.

Plaintiff Kimberly Anne Wilson, a resident of Baltimore, instituted this diversity case on February 17, 2004, against some 14 pharmaceutical enterprises alleging damages claims in four counts. The gravamen of her claims is that during 1956-57, while her mother was pregnant with plaintiff, plaintiffs mother ingested Diethylstilbestrol (“DES”). Consequently, plaintiff alleges, she has suffered numerous injuries, including but not limited to infertility and failed pregnancies. Most of the defendants have filed answers but some defendants have not yet appeared in the action. There has been no discovery and no ease management order has been issued.

On or about April 29, 2004, plaintiff sought from defendants their approval of a stipulation of voluntary dismissal without prejudice. Some of the defendants consented to the request, but several others declined to consent. Thereafter, plaintiff filed a motion pursuant to Fed.R.Civ.P. 41(a)(2) for leave to [100] dismiss her claims without prejudice.

Footnotes

Wilson v. Lilly, 222 F.R.D. 99, 2004 U.S. Dist. LEXIS 10834, 2004 WL 1305859 (D. Md. 2004).

222 F.R.D. 99 (Wilson v. Lilly) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rivera v. Altec, Inc.
D. Maryland, 2021
Covington v. Syngenta Corp.
225 F. Supp. 3d 384 (D. South Carolina, 2016)
Lang v. Manufacturers & Traders Trust Co.
274 F.R.D. 175 (D. Maryland, 2011)
Aventis Pasteur, Inc. v. Skevofilax
914 A.2d 113 (Court of Appeals of Maryland, 2007)